Insider Investment: Jeffrey Golman Acquired 8,000 Shares of Monroe Capital (MRCC); Cibc World Markets Cut By $11.49 Million Its Johnson & Johnson (JNJ) Position

Johnson & Johnson (NYSE:JNJ) Logo

Cibc World Markets Inc decreased Johnson & Johnson (JNJ) stake by 11.29% reported in 2018Q1 SEC filing. Cibc World Markets Inc sold 89,748 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Cibc World Markets Inc holds 705,276 shares with $90.38M value, down from 795,024 last quarter. Johnson & Johnson now has $327.01B valuation. The stock decreased 0.10% or $0.12 during the last trading session, reaching $121.92. About 809,477 shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 21, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 17/04/2018 – Johnson & Johnson 1Q Adj EPS $2.06; 08/05/2018 – J&J’s Janssen: Darzalex Is the First Monoclonal Antibody Approved for Newly Diagnosed Patients With Newly Diagnosed Multiple Myeloma; 15/05/2018 – Nutriband Inc. Announces the Appointment of Dr. Jeff Patrick as Chief Scientific Officer and to Head of Advisory Board; 26/03/2018 – CNBC Transcript: Alex Gorsky, Chairman & CEO, Johnson & Johnson; 23/04/2018 – CN RAIL INTERIM CEO JJ RUEST SPEAKS ON QUARTERLY CALL; 20/03/2018 – Johnson & Johnson Chief Financial Officer Dominic Caruso to Retire; 16/03/2018 – Johnson & Johnson: Transaction Was Contemplated in Guidance Provided on Jan. 23; 21/05/2018 – J&J: EMBOTRAP II STENT RETRIEVER FOR ISCHEMIC STROKE; 17/04/2018 – JNJ SAYS ACTELION IS DELIVERING AS EXPECTED; 16/03/2018 – Johnson & Johnson: LifeScan Had 2017 Net Revenue of About $1.5B

Investors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Ohio-based Hendley Co has invested 4.29% in Johnson & Johnson (NYSE:JNJ). Fort Washington Invest Advisors Oh has invested 1.51% of its portfolio in Johnson & Johnson (NYSE:JNJ). Northstar Asset Management Llc, Pennsylvania-based fund reported 42,727 shares. Employees Retirement Association Of Colorado has 0.41% invested in Johnson & Johnson (NYSE:JNJ) for 479,021 shares. Stewart & Patten Limited Liability Company invested in 204,967 shares or 5.08% of the stock. Tctc Holdings reported 87,042 shares. Moreover, Steinberg Asset Mgmt has 0.44% invested in Johnson & Johnson (NYSE:JNJ) for 23,144 shares. American Economic Planning Gp Adv, a New Jersey-based fund reported 24,240 shares. Phocas Financial accumulated 12,946 shares. Hedeker Wealth Ltd Liability Company reported 20,974 shares. Hills Bankshares & Tru holds 1.6% or 41,310 shares in its portfolio. Welch Grp Llc holds 184,524 shares or 2.99% of its portfolio. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Inv owns 0.24% invested in Johnson & Johnson (NYSE:JNJ) for 203,188 shares. Mcf Advsrs Ltd Liability Co reported 0.28% in Johnson & Johnson (NYSE:JNJ). Shell Asset Management Com reported 491,442 shares or 1.25% of all its holdings.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.06 EPS, up 12.57% or $0.23 from last year’s $1.83 per share. JNJ’s profit will be $5.53 billion for 14.80 P/E if the $2.06 EPS becomes a reality. After $2.06 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $135.44’s average target is 11.09% above currents $121.92 stock price. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, June 13 by Cowen & Co. As per Thursday, October 19, the company rating was maintained by Credit Suisse. The rating was maintained by Jefferies on Friday, March 23 with “Buy”. As per Thursday, April 12, the company rating was upgraded by Credit Suisse. The company was maintained on Friday, July 14 by Jefferies. Jefferies maintained Johnson & Johnson (NYSE:JNJ) on Monday, February 26 with “Buy” rating. The firm earned “Hold” rating on Tuesday, July 18 by Stifel Nicolaus. The stock of Johnson & Johnson (NYSE:JNJ) earned “Neutral” rating by Citigroup on Tuesday, February 27. As per Thursday, January 26, the company rating was downgraded by Wells Fargo. The firm has “Neutral” rating given on Wednesday, April 20 by Goldman Sachs.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: which released: “Buy Johnson & Johnson” on June 20, 2018, also with their article: “What Are Johnson & Johnson’s Key Sources Of Revenue?” published on June 20, 2018, published: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” on June 20, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” published on June 01, 2018 as well as‘s news article titled: “Better Buy: Pfizer Inc. vs. Johnson & Johnson” with publication date: June 17, 2018.

Since February 15, 2018, it had 0 buys, and 1 insider sale for $20.17 million activity. Another trade for 155,342 shares valued at $20.17 million was sold by Stoffels Paulus.

Cibc World Markets Inc increased Cott Corp Que (NYSE:COT) stake by 69,963 shares to 673,730 valued at $9.92M in 2018Q1. It also upped Phillips 66 (NYSE:PSX) stake by 39,695 shares and now owns 50,027 shares. Petroleo Brasileiro Sa Petro (NYSE:PBR) was raised too.

Investors sentiment decreased to 0.81 in 2018 Q1. Its down 0.19, from 1 in 2017Q4. It dived, as 12 investors sold Monroe Capital Corporation shares while 15 reduced holdings. 7 funds opened positions while 15 raised stakes. 4.47 million shares or 7.90% less from 4.85 million shares in 2017Q4 were reported. Pnc Financial Serv Gru Inc owns 7,768 shares or 0% of their US portfolio. Moreover, Manufacturers Life Insur The has 0% invested in Monroe Capital Corporation (NASDAQ:MRCC) for 1,186 shares. Seabridge Lc holds 0% in Monroe Capital Corporation (NASDAQ:MRCC) or 606 shares. Clear Harbor Asset Ltd Liability Com holds 46,124 shares or 0.11% of its portfolio. Van Eck Associates invested 0.01% of its portfolio in Monroe Capital Corporation (NASDAQ:MRCC). Oppenheimer & Company Incorporated owns 60,019 shares. Blair William & Commerce Il reported 928,079 shares or 0.08% of all its holdings. Janney Montgomery Scott Llc accumulated 184,266 shares or 0.02% of the stock. Mckinley Cap Management Llc Delaware reported 137,220 shares or 0.1% of all its holdings. Wespac Advsr Ltd Co, California-based fund reported 64,925 shares. Mackenzie Financial holds 21,018 shares or 0% of its portfolio. Moreover, Asset Mgmt has 0.03% invested in Monroe Capital Corporation (NASDAQ:MRCC). Bridgeway Capital Mngmt, a Texas-based fund reported 61,403 shares. Wells Fargo And Mn holds 0% or 13,504 shares in its portfolio. Great West Life Assurance Com Can owns 5,348 shares for 0% of their portfolio.

Analysts await Monroe Capital Corporation (NASDAQ:MRCC) to report earnings on August, 14. They expect $0.37 earnings per share, up 5.71% or $0.02 from last year’s $0.35 per share. MRCC’s profit will be $7.49M for 9.23 P/E if the $0.37 EPS becomes a reality. After $0.42 actual earnings per share reported by Monroe Capital Corporation for the previous quarter, Wall Street now forecasts -11.90% negative EPS growth.

Director Jeffrey Golman of Monroe Capital Corp, paid for 8,000 of the firm shares worth $108,984 USD with an average of $13.6 price for each share. The chance of this acquisition remaining a secret is super low as it’s new, with the director now having rights to 10,000 shares – that is 0.05% of the company’s total market cap. The acquisition was unveiled in a SEC filing on June 21, 2018.

Another recent and important Monroe Capital Corporation (NASDAQ:MRCC) news was published by which published an article titled: “New Research: Key Drivers of Growth for Primo Water, Columbus McKinnon, Dominion Energy Midstream Partners, LP ..” on May 29, 2018.

Among 9 analysts covering Monroe Capital (NASDAQ:MRCC), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Monroe Capital has $1700 highest and $13.5 lowest target. $15.25’s average target is 11.64% above currents $13.66 stock price. Monroe Capital had 10 analyst reports since April 27, 2016 according to SRatingsIntel. JMP Securities maintained the stock with “Market Outperform” rating in Monday, November 13 report. As per Thursday, August 10, the company rating was upgraded by Ladenburg Thalmann. On Tuesday, March 27 the stock rating was initiated by FBR Capital with “Hold”. The firm has “Buy” rating by Janney Capital given on Wednesday, April 27. The stock of Monroe Capital Corporation (NASDAQ:MRCC) has “Neutral” rating given on Wednesday, August 10 by Ladenburg Thalmann. The stock has “Outperform” rating by Raymond James on Tuesday, August 16. Robert W. Baird downgraded it to “Neutral” rating and $16 target in Monday, January 9 report. Oppenheimer maintained the shares of MRCC in report on Wednesday, August 9 with “Buy” rating. The firm has “Buy” rating by Wunderlich given on Thursday, July 21.

Monroe Capital Corporation is a business development firm specializing in senior, unitranche and junior secured debt and to a lesser extent, unsecured debt and equity investments, and buyouts in middle-market companies. The company has market cap of $276.48 million. The fund prefers to invest in casinos and gaming, broadcasting, publishing, alcoholic beverage and tobacco distribution, gas and oil, insurance, pharmaceuticals and bio sciences, aerospace and defense, commercial printing, natural rubber, glass, container and packaging, metals and mining, and real estate. It has a 24.31 P/E ratio. It focuses to invest in the United States and Canada.

Monroe Capital Corporation (NASDAQ:MRCC) Institutional Positions Chart